Satellos Bioscience Inc. (TSX:MSCL)
Canada flag Canada · Delayed Price · Currency is CAD
17.27
-0.58 (-3.25%)
Mar 3, 2026, 4:00 PM EST

Satellos Bioscience Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Cash & Equivalents
19.340.0716.651.423.850.56
Short-Term Investments
15.318.4813.22---
Cash & Short-Term Investments
34.6148.5529.881.423.850.56
Cash Growth
99.91%62.49%2007.16%-63.21%583.78%-
Accounts Receivable
----00.03
Other Receivables
0.210.440.440.190.420.29
Total Trade Receivables
0.210.440.440.190.420.32
Other Current Assets
2.681.760.110.040.030
Total Current Assets
37.550.7430.431.654.310.89
Net Property, Plant & Equipment
0.0100.010.010.010
Other Intangible Assets
--2.962.895.65-
Long-Term Investments
--0.030.03--
Other Long-Term Assets
----5.65-
Total Assets
37.550.7533.434.579.960.89
Accounts Payable
3.53.582.742.091.660.17
Accrued Expenses
3.53.582.742.091.660.17
Total Current Liabilities
3.53.582.742.091.660.17
Long-Term Debt
-----0.86
Total Long-Term Liabilities
-----0.86
Total Liabilities
3.53.582.742.091.661.03
Common Stock
85.5578.1346.7322.2622.43.42
Additional Paid-in Capital
24.827.8719.833.521.950.19
Accumulated Other Comprehensive Income
-1.68-1.74-0.01-0.01-0-
Retained Earnings
-74.67-57.1-35.85-23.3-16.05-3.76
Total Common Shareholders' Equity
3447.1630.72.488.29-0.14
Shareholders' Equity
3447.1630.72.488.29-0.14
Total Liabilities & Equity
37.550.7533.434.579.960.89
Total Debt
-00000.86
Net Cash (Debt)
34.6148.5529.881.423.85-0.3
Net Cash Growth
-28.70%62.49%2007.16%-63.21%--
Net Cash Per Share
2.665.084.150.481.92-0.20
Book Value
3447.1630.72.488.29-0.14
Book Value Per Share
2.614.934.260.844.13-0.10
Tangible Book Value
3447.1627.74-0.42.65-0.14
Tangible Book Value Per Share
2.614.933.85-0.141.32-0.10
Updated Sep 30, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.